Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy). [electronic resource]
Producer: 20110223Description: 2027-31 p. digitalISSN:- 1096-9071
- Adolescent
- Adult
- Aged
- Antibodies, Neutralizing -- blood
- Antiviral Agents -- pharmacology
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- blood
- Interferon-gamma -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols -- pharmacology
- RNA, Viral -- blood
- Recombinant Proteins
- Ribavirin -- pharmacology
- Treatment Failure
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.